Innovation and Clinical Excellence for the Future of Brain Health
At the SAGA Clinical Studies Center, we believe that the future of neurology requires integrating clinical excellence, research, and timely access to innovative therapies.
Our Neurology Area brings together a team of highly specialized neurologists, positioning SAGA as a center with high-level clinical and operational capabilities for the development of highly complex clinical studies.
What does this mean for you? The impact of neurological diseases makes it necessary to generate new therapeutic alternatives. At SAGA, we are preparing to offer our patients specialized care and, progressively, access to cutting-edge treatments through research conducted under the highest ethical and safety standards.
Our Areas of Specialization
At SAGA we are working to transform the approach to the following conditions:
- Cerebrovascular disease and Stroke.
- Neuroimmunology and Multiple Sclerosis.
- Neuromuscular diseases.
- Parkinson’s disease and movement disorders.
- Neurodegenerative diseases.
- Complex neurological conditions.
Medical Leadership and Commitment
The area has a team of specialists in neuromuscular disorders, neuroimmunology, and cerebrovascular disease. Although the area is in the initial stage of protocol awards, the experience of our specialists and our installed capacity allow us to project ourselves as a highly competitive site that is prepared to host clinical studies in neurology.
Information for Institutions and Sponsors
SAGA offers a clinical-operational management model focused on quality, efficiency, and strategic recruitment, backed by solid institutional experience in clinical research.
Recruitment Capacity and Epidemiological Context
The sustained rise in chronic neurological diseases represents a strategic opportunity for the development of clinical research in Latin America:
- Stroke: Continues to be one of the leading causes of death and disability in Chile and worldwide.
- Parkinson’s disease: Shows a growing prevalence associated with population aging.
- Multiple Sclerosis: A neuroimmunological disease with a high functional impact, especially in young and economically active populations.
SAGA capitalizes on this scenario through a Referral and recruitment network and structured patient follow-up, ensuring a steady flow of candidates for intervention protocols.
Center Capabilities
Our structure is designed to meet the demands of modern research:
- Medical Team: Highly specialized neurologists and multidisciplinary coordination.
- Processes: Standardized clinical processes and rigorous traceability.
- Infrastructure: Geared toward highly complex studies with longitudinal follow-up.
Quality and Strategic Vision
Focus on medical excellence and operational capacity to comply with demanding protocols. SAGA embraces a vision of sustained growth in highly complex areas, offering sponsors a site prepared for the integration of excellent research and robust clinical processes.
Therapeutic Focus
Our operational capacity covers the spectrum of high-demand neurological indications:
- Cerebrovascular Disease: Focus on stroke and its impact on disability.
- Neuroimmunology: Protocols in Multiple Sclerosis and conditions with high social impact.
- Movement Disorders: Approach to Parkinson’s disease and neurodegenerative diseases associated with aging.
Are you looking for a site prepared for your next neurological protocol? Access operational capacity and medical excellence in Chile.
